Our Bureau

MUMBAI: The board of directors of Glenmark Pharmaceuticals Ltd has approved a bonus share issue in the ratio 1:1 or one share for every one held, the company said.

The bonus issue is to share the benefits of the company's growth with the shareholders, Mr Glenn Saldanha, Managing Director and Chief Executive Officer of the company, said in a statement.

The board's decision is subject to the approval of shareholders.

(This article was published in the Business Line print edition dated January 7, 2005)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.